Professor Martin Buxton
Honorary Professor - Life Sciences
Summary
Qualifications: BA (Soc Sci), Professor (1980-2014), Emeritus Professor (2014-)
Martin Buxton, Emeritus Professor of Health Economics and founder of Brunel's Health Economics Research Group. He has over 30 years experience in the methods and practice of economic evaluation in health care and has been involved in a large number of studies including: international drug trials, evaluations of national programmes for heart and liver transplantation, screening for breast cancer and abdominal aortic aneurysms, evaluation of pilot projects such as the picture archiving and communication system (PACS) at Hammersmith Hospital, assessments of the impact of medical audit and other organisational changes. He has been a member of the Appraisal Committee of the National Institute for Health and Clinical Excellence and has advised most of the major pharmaceutical companies.
Newest selected publications
Singh, J., Longworth, L., Baine, A., Lord, J., Orr, S. and Buxton, M. (2013) 'Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choices'. Health Services Research, 13 (249). pp. 249. ISSN: 1475-6773 Open Access Link
Chambers, JD., Lord, J., Cohen, JT., Neumann, PJ. and Buxton, MJ. (2013) 'Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate medicare expenditures'. Value in Health, 16 (4). pp. 629 - 638. ISSN: 1524-4733 Open Access Link
Anokye, NK., Pokhrel, S., Buxton, M. and Fox-Rushby, J. (2013) 'Physical activity in England: Who is meeting the recommended level of participation through sports and exercise?'. The European Journal of Public Health, 23 (3). pp. 458 - 464. ISSN: 1101-1262 Open Access Link
Thompson, SG., Brown, LC., Sweeting, MJ., Bown, MJ., Kim, LG., Glover, MJ., (2013) 'Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness'. Health Technology Assessment, 17 (41). pp. 1 - 118. ISSN: 1366-5278 Open Access Link
et al.Dere, W., Avouac, B., Boers, M., Buxton, M., Christiansen, C., Lawaetz, H., (2013) 'Erratum to: Recommendations for the Health Economics Analysis to be Performed with a Drug to be Registered in Prevention or Treatment of Osteoporosis'. Calcified Tissue International, 93 (2). pp. 1 - 1. ISSN: 0171-967X
et al.